MedTrace Logo

A Study to Design a Model Cohort for Analysis of Dyslipidemia (MK-0653A-204)

NCT01414192 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 3215

Last updated 2024-09-05

Study results available
· View outcomes & findings →

Summary

This study is being done to provide valid data on the evolution of a cohort of French participants treated with ezetimibe, alone or in combination with a statin, to be used in simulation models for cardiovascular disease (CVD). Patterns of drug use, evolution of risk factors for CVD, cardiovascular morbidity and mortality, and goal attainment in low density lipoprotein cholesterol (LDL-C) levels over time will be analyzed.

Conditions

Sponsors & Collaborators

  • Organon and Co

    lead INDUSTRY

Principal Investigators

  • Medical Director · Merck Sharp & Dohme LLC

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-11-15
Primary Completion
2014-09-15
Completion
2014-09-15

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01414192 on ClinicalTrials.gov